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by both bacterial strains, but to a higher extent by K12.  Con-
clusion: These findings indicate that genetically very similar 
 E. coli strains differ markedly in their ability to activate the 
inflammasome.  © 2014 S. Karger AG, Basel 
 Introduction 
 The inflammatory bowel diseases (IBD), Crohn’s dis-
ease (CD) and ulcerative colitis (UC) are chronic, relaps-
ing and remitting diseases that affect men and women 
equally, mainly starting in teenage years or young adult-
hood. IBD patients suffer from abdominal pain, diarrhea, 
rectal bleeding and weight loss  [1] . It has become evident 
in recent years that both genetic and environmental fac-
tors play a role in the pathology of IBD. The general un-
derstanding of IBD is that they are caused by a defect of 
the intestinal barrier function, which can be partially as-
signed to hereditary influences.
 The ‘hygiene hypothesis’ summarizes a number of ap-
proaches to explain increasing incidences of IBD in high-
ly developed, industrialized countries. Similar to allergies 
and asthma, IBD shows an inverse relationship with the 
degree of sanitation. This indicates that factors influenc-
ing the composition of the commensal gut flora are likely 
to play a role in IBD  [2] .
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 Abstract 
 Background: The probiotic bacterial strain  Escherichia coli 
Nissle 1917 (EcN) is used for the treatment of ulcerative coli-
tis (UC), diarrhea and constipation. Its beneficial effects in the 
treatment of UC have been demonstrated in several con-
trolled clinical studies; however, the mechanism of action on 
the cellular level is still not completely clear. The intracellular 
pattern recognition receptor NLRP3 is expressed in intestinal 
epithelial cells (IEC), activates caspase-1 within the inflam-
masome complex and has been implicated to play a role in 
the etiology of inflammatory bowel diseases.  Methods: Pro-
biotic EcN and commensal  E. coli K12 were applied to IEC in 
vitro. Inflammasome activation, interleukin (IL)-18 release 
and caspase-1 activation were determined by coimmuno-
precipitation, Western blot and ELISA. Apoptosis was inves-
tigated by Western blot.  Results: Incubation of Caco-2 cells 
with EcN resulted in lower inflammasome activation and 
subsequent secretion of mature IL-18 as compared to the 
commensal strain K12. Induction of apoptosis as determined 
by cleavage of caspase-3 and poly (ADP-ribose) polymerase 
were lower in EcN-stimulated cells. Autophagy was induced 
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 The modulation of the gut flora by probiotic bacteria 
is efficient for the treatment of different forms of diar-
rhea, pouchitis and UC  [3] . The current definition of pro-
biotic bacteria was described by the World Health Orga-
nization in 2001 as probiotics being ‘live microorganisms 
which when administered in adequate amounts confer a 
health benefit on the host’  [4] .
 Escherichia coli  Nissle 1917 (EcN), unlike other com-
mon probiotics, is a Gram-negative bacterium. For the 
treatment of UC, beneficial effects of EcN were demon-
strated in several controlled clinical trials, in which pa-
tients received either a standard therapy with 5-amino-
salicylic acid (5-ASA) or EcN. The efficacy of EcN in 
maintaining remission was comparable to that of 5-ASA 
 [5–7] . The mechanisms by which EcN exerts its positive 
effect are not clear. Studies with cell culture or animal 
models have identified several mechanisms, which might 
all contribute to the observed beneficial effect  [8] .
 Comparing the effects of probiotic EcN and of the 
commensal strain  E. coli K12 in intestinal epithelial cells 
(IEC), Kamada et al. [9] found that the presence of EcN 
suppressed TNF-α-induced interleukin (IL)-8 transcrip-
tion and production. Wehkamp et al. [10] and Schlee et 
al. [11] showed that EcN triggered the expression and 
production of human β-defensin 2 (HBD-2) via NF-κB 
signaling in Caco-2 cells. These findings are of particular 
interest with regard to IBD, since an altered defensin pro-
duction has also been demonstrated for IBD patients  [12, 
13] . A promising approach to target this defensin defi-
ciency is the construction of recombinant EcN which re-
lease HBD-2  [14] .
 Besides its function on inflammatory signaling, EcN 
also seems to positively influence the intestinal barrier 
function. The addition of EcN along with enteropatho-
genic  E. coli strains prevented epithelial cell membrane 
disruption and induced an induction and redistribution 
of the tight junction protein zonula occludens 2 (ZO-2) 
in T84 cell cultures  [15] . In mice, the induction of colitis 
by dextran sulfate sodium (DSS) and the parallel admin-
istration of EcN resulted in a less severe inflammation in 
both chronic and acute colitis models  [16] . For the acute 
model, this effect was later shown to be associated with an 
upregulation of ZO-1 in IEC of mice that had been treat-
ed with EcN  [17] . Another protective mechanism of EcN 
may arise from its ability to prevent adhesion and inva-
sion of epithelial cells by other pathogenic bacterial strains 
 [18, 19] .
 NLRP3 is an intracellular pattern recognition receptor 
which belongs to the family of NOD-like receptors (NLRs) 
of the innate immune system. Together with ‘apoptosis-
associated speck-like protein containing a caspase re-
cruitment domain’ (ASC) and caspase-1, NLRP3 forms 
the inflammasome, an intracellular signaling platform 
that is activated upon a number of microbial and nonmi-
crobial stimuli  [20] . Upon autocatalytic activation within 
the inflammasome complex, caspase-1 cleaves its sub-
strates pro-IL-1β and pro-IL-18 as well as pro-IL-33 into 
their mature isoforms, which are then released by the cell 
 [21] . IL-18 exerts its function by binding to the IL-18 re-
ceptor (IL-18R) which is present on macrophages, natu-
ral killer cells, dendritic cells, and most T cells. Here, IL-
18 induces the proliferation of its target cells and the tran-
scription of IFN-γ and other proinflammatory cytokines 
 [22] . The role of NLRP3 and IL-18 in IBD was demon-
strated with experimentally induced colitis in mice. Nlrp3 
knockout mice were shown to be more susceptible to 
DSS-induced colitis  [23–25] , accompanied by an im-
paired intestinal epithelial barrier function and an in-
creased bacterial translocation  [25] . In mice receiving 
DSS or TNBS for the induction of colitis, the concurrent 
treatment with IL-18-neutralizing antiserum or IL-
18-binding protein ameliorated the inflammatory symp-
toms of colitis  [26, 27] . Studies with transgenic mice re-
vealed that overexpression of IL-18 leads to a more severe 
DSS-induced colitis with an increased infiltration of mac-
rophages into the inflamed mucosa.
 Elevated IL-18 serum levels were found in patients 
with UC, and this increase was correlated with the sever-
ity of inflammation  [28] . Furthermore, IL-18 was more 
abundant in plasma and mucosa of CD patients as com-
pared to control subjects  [29–31] . Genome-wide associa-
tion studies have identified NLRP3 as susceptibility gene 
for CD  [32, 33] .
 The observed upregulation of proinflammatory IL-18 
in IBD, and the fact that the inflammasome complex to-
gether with NLRP3 and caspase-1 is an activator of IL-18 
led to the hypothesis that the beneficial effects of EcN 
might be mediated via this signaling pathway.
 Methods 
 Bacterial Cultures 
 Two Gram-negative  E. coli strains were used in this study. The 
probiotic strain EcN was cultivated from Mutaflor ® capsules (Ar-
deypharm, Herdecke, Germany), and commensal  E. coli strain 
K-12 (clone MG1655) was obtained from the German Collection 
of Microorganisms and Cell Cultures (DSMZ, Brunswick). In their 
exponential growth phase in Luria Broth (LB) medium, bacteria 
were frozen in glycerol stocks. The number of colony-forming 
units (CFU) in stocks was determined by plating serial dilutions 
on LB agar plates.
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 Incubations and Stimulations 
 The IEC line Caco-2/BBE was cultured in DMEM high-glucose 
(Life Technologies, Grand Island, N.Y., USA) containing 10% FCS 
and 1% penicillin and streptomycin at 37   °   C and 10% CO 2 . Prior 
to bacterial stimulation, the cell number was determined, and cul-
tivation medium was exchanged by medium without serum and 
antibiotics. Low-dose stimulation by bacteria used a multiplicity of 
infection (MOI) of 0.1, meaning that the ratio is one CFU of bac-
teria to 10 eukaryotic cells. Stimulations were performed for up to 
24 h with an MOI ranging from 0.1 to 100 as indicated.
 SDS-PAGE and Western Blot 
 After stimulation, cells were harvested with M-Per lysis buffer 
(Thermo Fisher Scientific, Rockford, Ill., USA) and additionally 
lysed by sonication. Cytosolic fractions were diluted to 15 μg of to-
tal protein in NuPAGE sample buffer containing 50 m M dithioth-
reitol (Sigma-Aldrich, St. Louis, Mo., USA), denatured by boiling 
at 95   °   C for 5 min, before loading onto Bis-Tris SDS-PAGE gels. 
Proteins were transferred to nitrocellulose membranes (Life Tech-
nologies) which were subsequently blocked with 3% milk in Tris-
buffered saline solution containing Tween-20 (TBS-T) for 1 h, and 
incubated with the primary antibodies overnight at 4   °   C. Primary 
antibodies against caspase-1 and poly (ADP-ribose) polymerase 
(PARP) were obtained from Cell Signalling (Danvers, Mass., USA), 
antibodies against occludin were obtained from Life Technologies, 
anti-IL-18 from Santa Cruz (Santa Cruz, Calif., USA) and anti- 
NLRP3 (NALP3b-y) from Alexis (Lausen, Switzerland). After 
washing three times with TBS-T, secondary antibodies coupled to 
horseradish peroxidase (Santa Cruz) were diluted in 3% milk in 
TBST and incubated for 1 h at room temperature. Chemilumines-
cence detection used ECL solution from GE Healthcare (Little 
Chalfont, UK), and densitometric analysis was performed with Op-
tiquant software (Packard Instrument Co., Meriden Conn., USA).
 Coimmunoprecipitation 
 For coimmunoprecipitation (Co-IP), 100 μg of cytosolic frac-
tions of protein lysates were used. In order to minimize unspecific 
binding to protein G sepharose beads (GE Healthcare), lysates 
were pre-cleared by rotating for 1 h at 4  °  C on a fraction of protein 
sepharose G which were then discarded. Only the supernatant 
containing pre-cleared lysate was used for immunoprecipitation 
with 1 μg of caspase-1 antibody (Santa Cruz) overnight at 4  °  C. On 
the following day, fresh protein G beads were added to each sample 
and allowed to bind to antibody precipitates for 1 h. After this, 
beads were spun down, washed with PBS, resuspended in sample 
buffer containing dithiothreitol and boiled for 10 min at 95  °  C. Su-
pernatants were subjected to commercially available gradient 
4–12% SDS-PAGE gels from Invitrogen, and subsequent Western 
blotting was performed as described above.
 Quantification of Cytokine Secretion 
 A commercially available ELISA to detect active forms of IL-18 
in cell culture supernatants was used according to the manufac-
turer’s instructions (MBL International, Woburn, Mass., USA).
 Statistics 
 One-way ANOVA analysis followed by post-hoc Tukey’s Mul-
tiple Comparison Test was used to evaluate the significance of the 
results. For analysis, GraphPad Prism ® Software 5.0 was used, and 
p values of <0.05 were considered statistically significant.
 Results 
 Inflammasome Assembly Induced by EcN and E. coli 
K12 
 The assembly of NLRP3 with caspase-1 is a crucial 
step in inflammasome activation. By recruitment of cas-
pase-1 to NLRP3 and ASC, caspase-1 is cleaved autocat-
alytically and can exert its action in cleaving its sub-
strates, pro-IL-1β and pro-IL-18. The interaction of 
NLRP3 and caspase-1 was investigated by Co-IP. An in-
creased assembly of caspase-1 and NLRP3 was found in 
cells treated with  E. coli K12 already at an MOI of 0.1 
( fig. 1 a), reflected by the enhanced signal of NLRP3 as 
detected by Western Blot analysis. In line with this, the 
activation of caspase-1 was investigated by assessing the 
appearance of cleaved isoforms of 10 and 20 kDa ( fig. 1 b). 
Although an increase in the 20 kDa isoform was detected 
in both EcN- and K12-stimulated cells, it was clearly 
more pronounced in IEC stimulated with the commensal 
K12 strain.
 Levels of Mature IL-18 Produced after Coincubation 
with EcN or E. coli K12 
 In the same experimental setup, we analyzed the turn-
over of one of the targets of caspase-1, namely pro-IL-18. 
Stimulation of CaCo-2 IEC with EcN did not induce the 
IP: caspase-1
WB: NLRP3
Caspase-1
p20
MOI – 0.1 1
EcN K12
10 0.1 1 10
a
b
c
75 kDa
20 kDa
IL-18
24 kDa
18 kDa
 Fig. 1. Activation of inflammasome components upon bacterial 
stimulation. Cells were stimulated with indicated amounts of bac-
teria for 24 h.  a Co-IP of caspase-1 and subsequent detection of 
NLRP3 in cells stimulated with K12 at an MOI of 0.1 revealed as-
sembly of the two inflammasome components.  b Caspase-1 activa-
tion was increased in cells stimulated with both strains of  E. coli as 
compared to nontreated cells, but more pronounced after K12 
stimulation.  c IL-18 was detected as inactive proform at 24 kDa 
under all conditions except in untreated cells, whereas the cleaved 
subunit (18 kDa) was detected only in K12-stimulated cells. West-
ern blot is representative of three independent experiments. 
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production of detectable amounts of mature IL-18 in cy-
tosolic lysates, while the non-cleaved (immature) pro-
form was clearly present. In contrast, the commensal 
 E.  coli wild-type strain K12, applied in concentrations 
ranging from MOI 0.1 to 10 induced increased levels of 
mature (active) IL-18 ( fig. 1 c).
 Once pro-IL-18 is cleaved by caspase-1, it is secreted 
by the cells, and can be detected in cell culture superna-
tants. A number of experiments were performed to better 
understand the kinetics of this activation and release. 
Stimulation with EcN or K12 for 6 h was not sufficient to 
trigger a robust activation and release of IL-18, as levels 
were close to the detection limit ( fig. 2 a). Since short in-
cubation periods were not sufficient to reach solid IL-18 
levels, a pulse-chase experiment was performed. A short, 
1-hour incubation with indicated amounts of either EcN 
or K12 was followed by a washing step and further incu-
bation of epithelial cells in bacteria-free, antibiotics-con-
taining medium for 24 h, which was subsequently ana-
lyzed for the presence of active IL-18 by ELISA ( fig. 2 b). 
In cells stimulated with K12 at an MOI of 100, the short 
coincubation time resulted in the secretion of significant-
ly higher amounts of IL-18 during the 24-hour period 
that followed K12 stimulation.
 In the third experimental approach, cells were stimu-
lated constantly for 24 h with low concentrations of both 
bacterial strains. To prevent bacterial overgrowth during 
the extended incubation period, only low concentrations 
of bacteria (MOI 0.1 and 1) were tested in this approach. 
This was sufficient to trigger IL-18 release in substantial 
amounts ( fig. 2 c). Both strains induced a significant in-
crease in IL-18 levels as compared to untreated control 
cells. Comparing the effects of EcN with that of  E. coli 
K12, levels of IL-18 were found to be significantly higher 
in cells incubated with K12 at an MOI of 0.1. Thus, the 
incubation of IEC with probiotic EcN led to significantly 
lower levels of IL-18 as compared to stimulation with the 
commensal strain K12.
 Induction of Apoptosis by EcN and E. coli K12 
 In the intestine of CD patients, increased apoptosis 
rates of IEC can be detected  [34] . Therefore, we tested 
whether apoptotic events are altered by the stimulation 
of IEC with the two  E. coli strains. Although the probi-
otic EcN strain induced a certain level of apoptosis in 
IEC, this effect was more pronounced in  E. coli K12-
treated cells.
 Most apoptotic events lead to activation of caspases, 
among them the effector caspase-3. Activation of cas-
pase-3 involves proteolytic cleavage and results in the ap-
pearance of the small subunit. In Caco-2 cells stimulated 
for 24 h with indicated concentrations of EcN or K12, this 
small subunit was detected by Western blot ( fig. 3 a). In 
contrast, no signal was observed in control cells, only the 
inactive pro-form was visible. The pro-form appeared 
more prominent in EcN-treated cells, suggesting less ac-
tivation of caspase-3. Densitometric analysis and calcula-
tion of the ratio of total caspase-3 versus cleaved cas-
0
1
2
3
4
5
IL-
18
 (p
g/m
l)
a
–MOI 0.1 1 10
EcN
0.1 1 10
K12
*
*
**
*
*
0
5
10
15
20
25
IL-
18
 (p
g/m
l)
b
–MOI 1 10 100
EcN
1 10 100
K12
***
*
*
*
0
20
40
60
IL-
18
 (p
g/m
l)
c
–MOI 0.1 1
EcN
0.1 1
K12
**
***
***
 Fig. 2. Bacterial stimulation leads to IL-18 secretion.  a IL-18 levels 
in cell culture supernatants of EcN- or K12-stimulated Caco-2 
cells were assessed by ELISA after 6 h, which detected only small 
increases.  b In a pulse-chase experiment, cells were stimulated for 
1 h, washed and incubated for 24 h with antibiotics.  c The release 
of IL-18 was significantly increased after 24 h under all stimula-
tion conditions as compared to nonstimulated cells. EcN caused 
lower secretion of IL-18 in both concentrations as compared to 
MOI 0.1 of K12-treated cells (n = 3,  *  p < 0.05,  * *  p < 0.01,  * * *  p < 
0.001). 
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pase-3 revealed that cells stimulated with K12 showed 
more pronounced caspase-3 activation ( fig. 3 b).
 In line with the finding that K12 triggers enhanced 
caspase-3 cleavage and thus apoptosis, we found that the 
target of caspase-3 PARP was cleaved more pronounced 
upon stimulation with the commensal strain of  E. coli 
( fig.  4 a, b). Interestingly, not only the cleaved PARP 
product was present to a greater extent in K12-treated 
cells, but also the pro-form. The expression of uncleaved 
PARP was significantly higher in cells stimulated with 
K12 at a MOI of 0.1 as compared to EcN-treated and con-
trol cells.
0
0.5
1.0
1.5
Cle
ave
d v
s. t
ota
l ca
spa
se-
3 r
ati
o
b
–MOI 0.1 1
EcN
0.1 1
K12
Caspase-3
35 kDa
19 kDa
a –MOI 0.1 1EcN 0.1 1K12
Fig. 3. Induction of apoptosis in IEC upon bacterial stimulation.  a Caco-2 cells stimulated with bacterial strains showed elevated levels of 
activated caspase-3.  b Densitometry points towards higher caspase-3 activation in K12-stimulated cells. Data are based on one experiment.
0
0.5
1.0
1.5
Cle
ave
d v
s. t
ota
l PA
RP
 ra
tio
b
–MOI 0.1 1
EcN
0.1 1
K12
0
1
2
3
Un
cle
ave
d P
AR
P v
s. a
cti
n r
ati
o
c
–MOI 0.1 1
EcN
0.1 1
K12
***
*********
***
Actin
PARP
115 kDa
89 kDa
a –MOI 0.1 1EcN 0.1 1K12
Fig. 4. Cleavage of PARP as a marker for 
apoptosis.  a Cells stimulated with indicat-
ed amounts of EcN or K12 for 24 h dis-
played increased and dose-dependent 
cleavage of PARP. In K12-stimulated cells, 
more cleaved, thus inactivated, PARP was 
detected.  b Densitometric analysis from 
three independent experiments revealed a 
trend towards higher rates of apoptosis 
only in K12-stimulated cells, although with 
no statistical significance.  c Normalization 
of the densitometric analysis of the un-
cleaved PARP isoform to actin reveals that 
a general upregulation of PARP was pres-
ent in EcN- and K12-stimulated cells as 
compared to untreated cells. Furthermore, 
a significant increase in PARP expression 
at higher EcN dose and both doses of K12 
as compared to the cells stimulated with 
MOI of 0.1 was detected (n  = 3,  * * *   p  < 
0.001).
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 A further prominent feature of CD is the finding that 
the intestinal barrier function is disrupted, allowing 
ions, water and bacteria to pass through the intestinal 
wall  [35] . EcN has been reported to positively influence 
transepithelial resistance, causing upregulation of the 
tight junction protein ZO-1 in IEC  [17] . To test whether 
another tight junction protein, occludin, is also regulat-
ed in IEC by the treatment with EcN or K12, the expres-
sion of occludin in Caco-2 cells after bacterial coincuba-
tion was examined by Western blot ( fig.  5 a). A slight 
increase in occludin expression was detected in all cells 
stimulated by K12 (MOI 0.1 and 1) and in those cells 
stimulated by EcN at an MOI of 1, although this increase 
was not statistically significant. The densitometric analy-
sis and calculation of occludin versus actin expression 
demonstrated that occludin expression was induced in a 
dose-dependent manner, and to a higher extent in K12-
stimulated cells ( fig. 5 b). As observed before with PARP, 
almost no changes were evident at the lower dose of EcN 
(MOI 0.1).
 Contact of IEC with Bacteria Is Required for the 
Observed Effects 
 Interestingly, secreted factors of both bacterial strains 
had only mild effects on apoptosis and occludin expres-
sion. To test whether the previously observed effects in 
IEC could also be mediated without physical contact of 
bacteria to host cells, a transwell system was used. Caco-2 
cells were grown in a 12-well plate, and bacteria were add-
ed to the apical compartment of a transwell membrane 
with an MOI of 1. Thus, bacteria were allowed to grow in 
close proximity of Caco-2 cells, but the transwell mem-
brane kept them separated at all times. After 24 h, super-
natants and cell lysates were harvested and analyzed by 
ELISA and Western blot, respectively. PARP, a target of 
caspase-3, showed increased cleavage upon stimulation 
with any of the bacterial strains ( fig. 6 a, b). At the same 
time, the tight junction protein occludin appeared to be 
slightly upregulated by secreted factors of EcN and K12, 
but – as already stated above for occludin expression after 
direct stimulation with bacteria – densitometric and sta-
tistical analysis did not result in statistically significant 
changes of occludin expression ( fig.  6 a, c). Analysis of 
supernatants for the presence of IL-18 yielded no results, 
as IL-18 levels were below the detection limit (data not 
shown).
 Discussion 
 The stimulation of IEC with low and high doses of 
probiotic EcN and commensal  E. coli K12 resulted in a 
marked secretion of active IL-18 only in K12-stimulated 
cells. In line with this finding, NLRP3-inflammasome ac-
tivation was observed mainly in cells stimulated with 
K12.
 The comparison of probiotic EcN with commensal 
 E. coli K12 reveals differences in NLRP3-inflammasome 
activation and the apoptosis pathway. Interestingly, as-
sembly of NLRP3, activation of caspase-1 and secretion 
of IL-18 were all lower in EcN-treated cells as compared 
to cells treated with the commensal  E. coli K12 strain. This 
is remarkable as there is a high genetic similarity between 
EcN and K12. Nevertheless, the inflammasome system or 
upstream signaling pathways obviously are able to dis-
criminate between the two very similar bacterial strains.
 Our findings support the concept that commensal 
 E. coli cause more proinflammatory and proapoptotic sig-
0
0.5
1.0
1.5
2.0
2.5
Oc
clu
din
 vs
. ac
tin
 ra
tio
b
–MOI 0.1 1
EcN
0.1 1
K12
Occludin
Actin
a –MOI 0.1 1EcN 0.1 1K12
Fig. 5. Occludin expression in response to 
 E. coli stimulation. Protein expression of 
occludin appeared to be increased upon 
stimulation of Caco-2 cells with indicated 
concentrations of EcN or K12, although 
densitometric analysis and statistical anal-
ysis did not reach significance (n = 3).
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naling in IEC compared to EcN, which has already been 
observed in professional immune cells before  [36, 37] .
 Contrasting effects on cytokine stimulation in IEC 
have been described for a different probiotic bacterial 
strain of the species  Lactobacillus acidophilus  [38] .
 The cell culture model used in this study, of course, 
simplifies the situation that is normally present in the gut. 
Cells of the innate immune system, in addition, modulate 
IEC responses, and EcN has also pronounced effects on 
these cells  [39] .
 How can the differential activation and assembly of the 
inflammasome by the two  E. coli strains be explained? 
Certainly, an unselective binding of bacterial outer mem-
brane-derived lipopolysaccharide to TLR4 cannot be the 
discriminator. TLR4 has been suggested to mediate a 
number of EcN effects in dendritic cells  [40] . However, 
there are two arguments against an important role of 
TLR4 in our experimental setting. First, normal IEC ex-
press only low amounts of TLR4 (at least in our hands) 
 [41] . Second, our data indicate that either a direct bacte-
rial-epithelial cell contact or the presence of intact bacte-
ria is required for the observed effects on inflammasome 
assembly. This would not be the case if TLR4 binding was 
sufficient to induce the investigated effects.
 It is, however, possible that the reported upregulation 
of TLRs on the surface of IEC upon contact with com-
mensal bacteria leads to an increase in substrates for in-
flammasome cleavage  [42] . The TLR/MyD88 signaling 
pathway induces the proinflammatory transcription fac-
tors NF-κB and AP-1, which, among others, induce the 
transcription of the genes for IL-1β and IL-18, the sub-
strates for caspase-1 cleavage. This can be regarded as the 
priming step for inflammasome activation, which ap-
pears to be necessary for efficient cleavage of pro-IL-1β 
and pro-IL-18 by the NLRP3 inflammasome. The activa-
tion step of the NLRP3 inflammasome is still not fully 
understood, and several mechanisms have been proposed 
in the literature  [43] . Apart from a priming step, the pres-
ence of extracellular ATP, subsequent activation of the 
P2X7 receptor and pannexin-1 pore formation leading to 
an efflux of K + ions is a common hallmark preceding 
NLRP3 activation  [20, 44] . The endocytosis of anorganic 
particles such as asbestos  [45] and of crystals of uric acid 
 [46] has been proposed to cause lysosomal rupture, which 
leads to the release of reactive oxygen species. Although 
commensal  E. coli and EcN are noninvasive bacterial 
strains, the endocytosis of another  E. coli strain into IEC 
was observed when metabolic stress was induced  [47] . In 
this context, endocytosis and transcytosis may explain 
why otherwise noninvasive bacterial strains may be able 
to activate the intracellular pattern recognition receptor 
NLRP3. The elevated IL-18 levels, increased caspase-1 ac-
tivation and NLRP3-inflammasome assembly observed 
in this study indicate an involvement of the NLRP3-in-
flammasome in response to these bacterial stimuli.
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Fig. 6. Secreted factors of both bacterial strains have a mild effect 
on IEC.  a Caco-2 cells were grown on a 12-well plate, and bacteria 
were added to the apical compartment of a transwell membrane 
with an MOI of 1.  b PARP, a target of caspase-3, showed slightly 
increased cleavage upon stimulation of IEC with any of the bacte-
rial strains as determined by densitometric analysis.  c At the same 
time, the tight junction protein occludin was not significantly up-
regulated by secreted factors of EcN and K12. One Western blot 
detecting PARP, occludin and actin loading control is representa-
tive of three independent experiments.
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